These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 19154482)

  • 61. Aspergillus galactomannan antigen assay in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis.
    Park SY; Lee SO; Choi SH; Sung H; Kim MN; Choi CM; Hong SB; Oh YM; Shim TS; Koh Y; Kim YS; Woo JH; Kim SH
    J Infect; 2010 Dec; 61(6):492-8. PubMed ID: 20833201
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Galactomannan testing and Aspergillus PCR in same-day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis.
    Eigl S; Hoenigl M; Spiess B; Heldt S; Prattes J; Neumeister P; Wolfler A; Rabensteiner J; Prueller F; Krause R; Reinwald M; Flick H; Buchheidt D; Boch T
    Med Mycol; 2017 Jul; 55(5):528-534. PubMed ID: 27744310
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparison of PCR-ELISA and galactomannan detection for the diagnosis of invasive aspergillosis.
    Scotter JM; Campbell P; Anderson TP; Murdoch DR; Chambers ST; Patton WN
    Pathology; 2005 Jun; 37(3):246-53. PubMed ID: 16175901
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Outcome and medical costs of patients with invasive aspergillosis and acute myelogenous leukemia-myelodysplastic syndrome treated with intensive chemotherapy: an observational study.
    Slobbe L; Polinder S; Doorduijn JK; Lugtenburg PJ; el Barzouhi A; Steyerberg EW; Rijnders BJ
    Clin Infect Dis; 2008 Dec; 47(12):1507-12. PubMed ID: 18990068
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Hema e-Chart registry of invasive fungal infections in haematological patients: improved outcome in recent years in mould infections.
    Nosari AM; Caira M; Pioltelli ML; Fanci R; Bonini A; Cattaneo C; Castagnola C; Capalbo SF; De Fabritiis P; Mettivier V; Morselli M; Pastore D; Aversa F; Rossi G; Pagano L;
    Clin Microbiol Infect; 2013 Aug; 19(8):757-62. PubMed ID: 23279327
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Galactomannan antigen enzyme-linked immunosorbent assay for diagnosis of invasive aspergillosis after hematopoietic stem cell transplantation.
    Foy PC; van Burik JA; Weisdorf DJ
    Biol Blood Marrow Transplant; 2007 Apr; 13(4):440-3. PubMed ID: 17287156
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Immune reconstitution inflammatory syndrome in cancer patients with pulmonary aspergillosis recovering from neutropenia: Proof of principle, description, and clinical and research implications.
    Miceli MH; Maertens J; Buvé K; Grazziutti M; Woods G; Rahman M; Barlogie B; Anaissie EJ
    Cancer; 2007 Jul; 110(1):112-20. PubMed ID: 17525971
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Invasive Aspergillus infections in allo-SCT recipients: environmental sampling, nasal and oral colonization and galactomannan testing.
    Nihtinen A; Anttila VJ; Richardson M; Ruutu T; Juvonen E; Meri T; Volin L
    Bone Marrow Transplant; 2010 Feb; 45(2):333-8. PubMed ID: 19617902
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Serum galactomannan assay for the diagnosis of invasive aspergillosis in children with haematological malignancies.
    Jha AK; Bansal D; Chakrabarti A; Shivaprakash MR; Trehan A; Marwaha RK
    Mycoses; 2013 Jul; 56(4):442-8. PubMed ID: 23369047
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Therapy with antifungals decreases the diagnostic performance of PCR for diagnosing invasive aspergillosis in bronchoalveolar lavage samples of patients with haematological malignancies.
    Reinwald M; Hummel M; Kovalevskaya E; Spiess B; Heinz WJ; Vehreschild JJ; Schultheis B; Krause SW; Claus B; Suedhoff T; Schwerdtfeger R; Reuter S; Kiehl MG; Hofmann WK; Buchheidt D
    J Antimicrob Chemother; 2012 Sep; 67(9):2260-7. PubMed ID: 22740590
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Bronchogenic carcinoma and secondary aspergillosis--common yet unexplored: evaluation of the role of bronchoalveolar lavage-polymerase chain reaction and some nonvalidated serologic methods to establish early diagnosis.
    Shahid M; Malik A; Bhargava R
    Cancer; 2008 Aug; 113(3):547-58. PubMed ID: 18521930
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Detection of 1,3-beta-D glucan for diagnosis of invasive fungal infections in hematooncological patients: usefulness for screening of invasive mycosis and for confirmation of galactomannan positive results].
    Rácil Z; Kocmanová I; Weinbergerová B; Winterová J; Lengerová M; Hrncírová K; Mayer J
    Klin Mikrobiol Infekc Lek; 2009 Apr; 15(2):48-57. PubMed ID: 19488961
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Clinical utility and prognostic value of bronchoalveolar lavage galactomannan in patients with hematologic malignancies.
    Luong ML; Filion C; Labbé AC; Roy J; Pépin J; Cadrin-Tourigny J; Carignan S; Sheppard DC; Laverdière M
    Diagn Microbiol Infect Dis; 2010 Oct; 68(2):132-9. PubMed ID: 20846585
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Twenty-nine cases of invasive aspergillosis in neutropenic patients.
    Saghrouni F; Ben Youssef Y; Gheith S; Bouabid Z; Ben Abdeljelil J; Khammari I; Fathallah A; Khlif A; Ben Saïd M
    Med Mal Infect; 2011 Dec; 41(12):657-62. PubMed ID: 22036518
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Using the galactomannan antigen assay in the diagnosis of invasive aspergillosis after hematopoietic stem cell transplantation.
    Tănase AD; Coliţă A; Mărculescu A; Berteanu C; Streinu Cercel A; Stoica M; Stoica A; Cernea D; Copotoiu S; Brînzaniuc K; Azamfirei L
    Rom J Morphol Embryol; 2012; 53(2):379-82. PubMed ID: 22732810
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [The use of galactomannan detection in diagnosing invasive aspergillosis in hemato-oncological patients].
    Rácil Z; Kocmanová I; Wagnerová B; Winterová J; Lengerová M; Moulis M; Mayer J
    Vnitr Lek; 2008 Jan; 54(1):45-52. PubMed ID: 18390117
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Serum galactomannan versus a combination of galactomannan and polymerase chain reaction-based Aspergillus DNA detection for early therapy of invasive aspergillosis in high-risk hematological patients: a randomized controlled trial.
    Aguado JM; Vázquez L; Fernández-Ruiz M; Villaescusa T; Ruiz-Camps I; Barba P; Silva JT; Batlle M; Solano C; Gallardo D; Heras I; Polo M; Varela R; Vallejo C; Olave T; López-Jiménez J; Rovira M; Parody R; Cuenca-Estrella M; ; ; ;
    Clin Infect Dis; 2015 Feb; 60(3):405-14. PubMed ID: 25336623
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Lung resection for invasive pulmonary aspergillosis in neutropenic patients with hematologic diseases.
    Reichenberger F; Habicht J; Kaim A; Dalquen P; Bernet F; Schläpfer R; Stulz P; Perruchoud AP; Tichelli A; Gratwohl A; Tamm M
    Am J Respir Crit Care Med; 1998 Sep; 158(3):885-90. PubMed ID: 9731021
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Utility of galactomannan antigen detection in bronchoalveolar lavage fluid in immunocompromised patients.
    Brownback KR; Pitts LR; Simpson SQ
    Mycoses; 2013 Sep; 56(5):552-8. PubMed ID: 23496321
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Bronchoalveolar lavage in immunocompromised patients with haematological malignancy--value of new microbiological methods.
    Hohenthal U; Itälä M; Salonen J; Sipilä J; Rantakokko-Jalava K; Meurman O; Nikoskelainen J; Vainionpää R; Kotilainen P
    Eur J Haematol; 2005 Mar; 74(3):203-11. PubMed ID: 15693789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.